Get the Stockscreener App
33.61
3.92%
-1.37
After Hours:
33.28
-0.33
-0.98%
Moderna Inc Stock (MRNA) Latest News
Moderna (NASDAQ:MRNA) Trading Down 4.7%Here's Why - MarketBeat
Robeco Institutional Asset Management B.V. Reduces Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Pacer Advisors Inc. Sells 20,901 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Spire Wealth Management Purchases 22,192 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
3 Top AI-Powered Biotech Stocks to Buy in February - The Motley Fool
Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now? - AOL
Is Moderna Stock A Sell With Robert F. Kennedy Eyeing The Lead Role At HHS? - Yahoo! Voices
KBC Group NV Sells 38,943 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Do Wall Street Analysts Like Moderna Stock? - Nasdaq
Everett Harris & Co. CA Invests $275,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Why Moderna, Inc. (MRNA) Went Down on Tuesday - Yahoo Finance
Why Moderna Inc. (MRNA) Crashed on Monday - MSN
Moderna call volume above normal and directionally bullish - TipRanks
Global mRNA Vaccines and Therapeutics Market is expected - openPR
Moderna and BioNTech shares fall after Senate committee vote RFK Jr. - Investing.com Canada
This Is What Whales Are Betting On Moderna - Benzinga
Swedbank AB Raises Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna reports record for UK clinical trials in 2023/24 -February 04, 2025 at 06:31 am EST - Marketscreener.com
Moderna reports record for UK clinical trials in 2023/24 - European Pharmaceutical Review
Moderna, Inc. (NASDAQ:MRNA) Receives $67.26 Consensus Target Price from Analysts - MarketBeat
Moderna secures EU deal for mRNA COVID-19 vaccine supply - MSN
U.S. Markets Closed Down Monday; Moderna Took Biggest Hit - Barron's
Moderna Options Trading: A Deep Dive into Market Sentiment - Benzinga
Moderna touts UK R&D and manufacturing progress - The Pharma Letter
Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates? - Yahoo Finance
Moderna, Inc.'s (NASDAQ:MRNA) Business And Shares Still Trailing The Industry - Simply Wall St
MODERNA WAS THE LARGEST INDUSTRY SPONSOR OF CLINICAL TRIALS IN THE UK IN 2023/24 AS CONSTRUCTION ON MODERNA INNOVATION AND TECHNOLOGY CENTRE IN OXFORDSHIRE NEARS COMPLETION - PharmiWeb.com
Moderna: The Good News Isn't Enough (NASDAQ:MRNA) - Seeking Alpha
Objective long/short (MRNA) Report - Stock Traders Daily
Moderna (NASDAQ:MRNA) Shares Gap Down After Analyst Downgrade - MarketBeat
Discover Why Moderna's Stock Could Skyrocket in 2025! - Jomfruland.net
Why Are Analysts Bullish on Moderna, Inc. (MRNA) Now? - MSN
Exchange Traded Concepts LLC Has $1.09 Million Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna (NASDAQ:MRNA) Price Target Lowered to $99.00 at The Goldman Sachs Group - MarketBeat
Moderna (NASDAQ:MRNA) Rating Lowered to Neutral at The Goldman Sachs Group - MarketBeat
Moderna Stock Price | MRNA Stock Quote, News, and History - Markets Insider
The Goldman Sachs Group Has Lowered Expectations for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat
March 14th Options Now Available For Moderna (MRNA) - Nasdaq
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know - MSN
Why Moderna (MRNA) Crashed on Wednesday? - Yahoo Finance
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine - Pulmonology Advisor
S&P 500 Gains and Losses Today: Moderna Stock Plunges After Analyst Downgrade - MSN
Decoding Moderna's Options Activity: What's the Big Picture? - Benzinga
Moderna Shares Fall After TD Cowen Cuts Price Target -January 29, 2025 at 02:55 pm EST - Marketscreener.com
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines - AOL
Why MRNA Stock Is Retreating - Yahoo Finance
Moderna Stock Is Sliding Wednesday: Here's Why - Benzinga
Moderna Stock Falls After Goldman Downgrade. Vaccine Sales Are a Worry. - MSN
Moderna stock drops as Goldman Sachs cuts rating By Investing.com - Investing.com Canada
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):